Frequently Asked Questions About Ubiquinol Gummy Manufacturing

Ubiquinone and Ubiquinolare two forms of CoQ10 naturally produced in the body. Ubiquinone is theoxidized form of CoQ10 – the typical form found in conventional CoQ10supplements – which your body must convert into ubiquinol to utilize. Ubiquinolis the active, antioxidant form – essentially CoQ10 with two extraelectrons –a potent antioxidant and that directly participates in cellularenergy production. The difference matters because conversion efficiencyvaries; especially as people age or take certain medications (likestatins), the body’s ability to convert ubiquinone to ubiquinol slows down.By supplementing with Kaneka Ubiquinol®, you provide CoQ10 in the form yourbody uses immediately, bypassing the conversion step. In practical terms, takinga Kaneka Ubiquinol® supplement  yieldshigher total CoQ10 levels in the blood compared to taking the same dose ofubiquinone. For instance, a human crossover study found that ubiquinol producedpeak blood concentrations ~2.2× higher than ubiquinone and delivered 3.4×greater total CoQ10 exposure (AUC) over time. The upshot: ubiquinol ismore bioavailable, meaning more of it reaches target tissues afterabsorption. This distinction is why ubiquinol is generally regarded as thesuperior form of CoQ10 for dietary supplements, particularly in premiumor high-efficacy product lines. [scienceinsights.org]

Yes –numerous studies indicate ubiquinol can achieve higher blood CoQ10 levels thanubiquinone in many individuals, especially in older adults or those withreduced conversion capacity. For example, in one clinical trial olderparticipants taking ubiquinol had a 4.3-fold higher CoQ10 blood AUC(overall exposure) compared to those taking an identical dose of ubiquinone. Inhealthy adults, ubiquinol often produces about 3× the peak plasmaconcentration of standard CoQ10. These findings suggest improvedbioavailability with ubiquinol. That said, it’s also recognized thatformulation plays a critical role: a well-formulated ubiquinone (e.g.,dissolved in oil) can perform better than a poorly formulated ubiquinol. Ourpatented gummy platform addresses both factors – it uses the activeubiquinol formand an advanced formulation for delivery – to ensure optimalabsorption. Bottom line: ubiquinol’s absorption advantage is supportedby peer-reviewed research, and our platform is designed to fully capitalizeon that advantage for your product.

Kaneka Ubiquinol® appeals to health-conscious consumers seeking the most effectiveCoQ10 form, particularly adults over 40, those on statin therapy,and individuals with demanding health regimens (athletes, fertility planning,etc.). Older consumers often prefer ubiquinol because natural CoQ10 levelsdecline with age and ubiquinol may help more directly replenish thoselevels. Similarly, customers who’ve done their research know that statinmedications can deplete CoQ10, so taking the active ubiquinol form is aproactive way to maintain adequate CoQ10 levels. In general, Kaneka Ubiquinol®products are seen as premium, clinical-grade supplements – so the targetaudience is willing to invest in a higher-cost product for potential greaterefficacy. A Kaneka Ubiquinol® gummy specifically broadens theappeal: it combines the convenience and pleasant experience of gummies(no pills to swallow) with a science-backed ingredient. This can attractboth mainstream wellness consumers (who love gummies) and more advancedsupplement users (who insist on ubiquinol form). By offering a Ubiquinol gummy,your brand addresses a wider market segment – from older wellnesscustomers to younger individuals who simply prefer gummies but still want the bestform of CoQ10. 

Many brands decide it is –they treat Kaneka Ubiquinol® as a premium upgrade that commands a higherprice point and margin while delivering a real value-add. Kaneka Ubiquinol®’sproduction is more complex (it’s less stable, requires special handling, and isbacked by quality manufacturing processes), which makes it more expensive thanubiquinone per kg. Kaneka Ubiquinol® is also bioidentical to the body’snaturally produced ubiquinol. However, the marketing differentiation andperceived value by consumers often justify that cost. Customers who areknowledgeable about CoQ10 are generally willing to pay more for a KanekaUbiquinol® supplement because they associate it with better absorption andefficacy. For your brand, this can mean higher unit revenue and aproduct that stands out in the crowded CoQ10 category. Moreover, because ourgummy platform is patent-protected, you have a unique angle (first and onlyubiquinol gummy) that can support a premium pricing strategy. In summary: yes, KanekaUbiquinol® may cost more as an ingredient, but the ROI is evident inenhanced product positioning, stronger consumer trust, and the ability toaddress the premium segment of the market that seeks out “the best”ingredients.

Launching this product immediately places your brand at the fore front of innovationin the CoQ10 category. You’ll be offering the first-to-market KanekaUbiquinol® gummy, which none of your competitors currently have (thanks to the exclusivity of GPG’s platform). This differentiation operates on multiple levels:
- Format Differentiation: It’s a gummy– the fastest-growing supplement format globally, favored for convenience andtaste, now applied to a typically capsule-only ingredient. This could attract customers who avoid pills, expanding your reach.
- Ingredient Differentiation: It uses Kaneka Ubiquinol®, widely recognized as the gold-standard CoQ10 ingredient. Many leading supplement brands already highlight “Kaneka Ubiquinol®” on their labels as a mark of quality. By including that same trusted ingredient in a new format, you leverage both novelty and credibility.
- Brand Story: You can tell a compelling story of science and partnership – that your brand is delivering aproduct enabled by patented technology and collaboration with the industry’s CoQ10 leader (Kaneka). This elevates your brand’s authority in the eyes of retailers and consumers. In short, a Kaneka Ubiquinol® gummy becomes a flagship, differentiation SKU in your line, signaling that your brand leads in both innovation and quality.

The key is to simplify the science into consumer-friendly points, whiler emaining compliant. You might emphasize that Ubiquinol is the “active antioxidantform of CoQ10 that your body can use directly” (unlike standard CoQ10 that needs conversion). Also highlight benefit-oriented language: e.g., “supports heart health and energy at the cellular level,”“helps replenish CoQ10 levels as you age,” and “provides powerful antioxidant support”. Those messages resonate with consumers and are permissible structure/functionclaims. Avoid technical jargon or overt comparisons that implysuperiority in a way that could draw regulatory scrutiny (for instance, don’texplicitly say “absorbs 2x better” on consumer packaging, unless you plan to reference a study in fine print). Instead, you can incorporate education in blogs or online content by citing research findings — e.g., mentioning that studies have shown ubiquinol yields higher blood CoQ10 levels than ubiquinone. We can supply you with scientifically accurate, consumer-friendly copy and infographics, such as analogies (e.g., “ubiquinol is like a charged batteryready to work”), that help convey ubiquinol’s benefits without crossingregulatory lines. Ultimately, clear messaging that “Ubiquinol = advanced CoQ10 for enhanced support” will help consumers understand why your productis special.

Retailers are very interested in innovative gummy products, and a Kaneka Ubiquinol® gummy hits two trends: gummies (the #1 growth format in supplements) and Kaneka Ubiquinol® (a premium ingredient with strong backing). Mainstreamretailers (pharmacies, health stores) have started to carve out shelf spacespecifically for ubiquinol products alongside general CoQ10, as consumer awareness grows. By offering ubiquinol in a gummy, your product can stand out in both the CoQ10 category and the gummies section. We anticipate that retailers will view it as a unique SKU that caters to unmet demand (gummy lovers who want high-end actives). In terms of market data: Conventional CoQ10 supplements (ubiquinone) are a major category, but the ubiquinol sub-category has been steadily growing as more brands and consumers adopt it for its perceived benefits. Being first with a gummy format gives you novelty leverage in conversations with category buyers. You can underline that this product is backed by Kaneka and patented technology, which adds credibility and excitement from a retail perspective. Overall, we expect strong interest due to the confluence of a trusted ingredient, a trending delivery form, and exclusivity – a combination that helps retailers differentiate their offerings, too.

Global Products Group supplies comprehensive stability data demonstrating that each gummy (100 mg Ubiquinol) remains within potency specification for at least 24 months under ambient storage conditions. Our stability reports (withfull testing protocols and results) are available for regulatory submissions and due diligence. These include real-time and accelerated stability profiles showing minimal oxidation of Ubiquinol over time and compliance with global supplement shelf-life guidelines. We also provide a detailed Certificate of Analysis (COA) for each batch, verification of Kaneka Ubiquinol® raw material quality (purity ≥ 96% and ubiquinone ≤ 2% per USPspec), and any other data needed to support label shelf-life claims or productquality during audits.

All production occurs at our FDA-registered facility in Florida, adhering to 21 CFR Part 111 dietary supplement GMPs. We run a validated manufacturing process for the Ubiquinol gummy, including in-process controls (core fill volume, shell integrity, etc.) and rigorous QC testing on finished gummies (assaying Ubiquinol content, ubiquinone content, and uniformity via HPLC). Our Quality Assurance team, in collaboration with Kaneka’s technical staff, oversees each batch. We maintain traceability and documentation (Master Batch Records, Certificates of Analysis, stabilityprotocols) to facilitate any partner audits or regulatory reviews. In short, we meet the same high quality standards as pharmaceutical-grade gummy products, ensuring your branded product is backed by robust quality systems.

Yes. We encourage and support partner brands in using the Kaneka Ubiquinol® trademark on packaging and marketing materials, as it signals quality and ingredient authenticity. We provide official Kaneka Ubiquinol® logo files and require the“®” symbol on first use of the name. The ingredient should be listed in theSupplement Facts as “Ubiquinol (Kaneka Ubiquinol®)” for transparency. [JF1]The Active‑Saver™ name may be referenced in B2B contexts or technicaldocumentation to describe the core gel stabilization technology. Forconsumer-facing materials, it’s optional; if used (e.g., on a website orproduct info sheet), use the “™” symbol and a brief descriptor like “patent-pending Active‑Saver™ core gel technology to stabilize Ubiquinol.” We will provide trademark usage guidelines to ensure compliance and consistency. As part of our licensing agreement, it is a requirement for the brands to place the Kaneka quality seal on their packaging and also name Kaneka Ubiquinol® as the active ingredient.

The finished product is a dietary supplement, so only structure/function claims are permitted, not any disease claims. For example, you can say the product “supports heart health and cellular energy” or “helps maintain cardiovascular health in conjunction with a healthy lifestyle,”which are common, FDA-compliant statements for CoQ10 supplements. You cannot claim to treat or prevent specific diseases (e.g., no mention of heart disease, hypertension, or curing statin side effects). We will assist your regulatory team with a list of appropriate claims (e.g., relating to heart health, energy metabolism, antioxidant support, healthy aging) that align with FDA/FTC guidelines and are supported by Kaneka’s scientific evidence. Additionally, your product label must include the standard FDA disclaimer(“This statement has not been evaluated by the FDA…”) since structure/functionclaims are being made.

No special packaging is required. One advantage of our patented Active‑Saver™ barrier system is that it protects the final gummy product in standard packaging configurations (e.g., HDPE or PET bottles with typical liner ordesiccant) for the full shelf life. We recommend the usual best practices forsupplement packaging: using opaque, air-impermeable bottles (to limitlight and oxygen exposure). But no unusual blister packs or refrigeration areneeded. The validated 24-month shelf life is achieved under ambient conditions (≈25°C, 60% RH), so the product remains stable in typical retailand consumer environments. We do advise storing the product in a cool, dry place and avoiding prolonged exposure to heat (above 30°C) to ensure maximumpotency retention, as is standard for Ubiquinol supplements.

Absolutely. As your manufacturing partner, we provide a complete documentation and support package to streamline your regulatory process. This includes our Master Product Technical Dossier, which covers formulation details, ingredient specifications, manufacturing flow, stability data, COAs, and any test method validations (e.g., our proprietary HPLC assay for Ubiquinol in gummies). We also welcome our partners’ quality audits of our facility and processes;our QA team will facilitate on-site or virtual audits to satisfy your vendorqualification protocols. Moreover, if you plan to register the product in markets outside the U.S., we can support you with any necessary technical information (e.g. for Novel Food or other regulatory approvals). Our goal is tomake the regulatory and QA phase as smooth as possible for your team, ensuring you have confidence and verification of all product claims and specifications.

The joint GPG × Kaneka patent (PCT/US2025/53409) covers a “gel compositioncontaining ubiquinol in a liquid center,” specifically the two-phase Active‑Saver™core gel + shell gummy architecture. Under an exclusive global IP licensing agreement with Kaneka, Global Products Group is the sole authorized manufacturer worldwide for Kaneka Ubiquinol® in gummy form. This means no other contract manufacturer or brand can legally produce a Kaneka Ubiquinol® gummy using this patented technology without our involvement. Forpartner brands, the patent exclusivity ensures a first-to-market and protected competitive advantage: your Ubiquinol gummy product will be uniquely enabled by a proprietary, patent-backed platform that competitors cannot duplicate.

As with any food and supplement manufacturing, the components dictate the shelf life. Our process and selective ingredient sourcing ensures the longest shelf life available; however, we are available to answer any additional question you may have about specific product formulations.